The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study

Robert Carreras‐Torres; Mattias Johansson; Valérie Gaborieau; Philip Haycock; Kaitlin H. Wade

doi:10.1093/jnci/djx012

The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study

Robert Carreras‐Torres, Mattias Johansson, Valérie Gaborieau, Philip Haycock, Kaitlin H. Wade, Caroline L. Relton, Richard M. Martin, George Davey Smith, Paul Brennan

Oxford University Press (2017) • Volume 109, Issue 9

PDF Available

Abstract

Our results suggest a causal role of BMI and fasting insulin in pancreatic cancer etiology.

Quick Actions

Read Full Paper

Publication Info

DOI

10.1093/jnci/djx012

Language

English

Topic

Pancreatic and Hepatic Oncology Research

Keywords

Mendelian randomization, Type 2 diabetes, Medicine, Dyslipidemia, Internal medicine, Pancreatic cancer, Insulin resistance, Odds ratio, Body mass index, Obesity, Oncology, Diabetes mellitus, Endocrinology, Cancer, Bioinformatics, Genetics, Biology, Genotype

Published

January 30, 2017

Citations

264 citations

FWCI

12.32

External Resources

DOI Link OpenAlex

The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study

Abstract

Quick Actions

Publication Info

External Resources

Suggested Papers

European guideline for the diagnosis and treatment of insomnia

A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity

Chemically induced skin carcinogenesis: Updates in experimental models (Review)

Suggested Papers

Suggested Papers

European guideline for the diagnosis and treatment of insomnia

A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity

Chemically induced skin carcinogenesis: Updates in experimental models (Review)